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Abstract
Background: We describe a biosensor platform for monitoring molecular interactions that is
based on the combination of a defined nano-porous silicon surface, coupled to light interferometry.
This platform allows the label-free detection of protein-protein and protein-DNA interactions in
defined, as well as complex protein mixtures. The silicon surface can be functionalized to be
compatible with traditional carboxyl immobilization chemistries, as well as with aldehyde-hydrazine
bioconjugation chemistries.
Results: We demonstrate the utility of the new platform in measuring protein-protein interactions
of purified products in buffer, in complex mixtures, and in the presence of different organic solvent
spikes, such as DMSO and DMF, as these are commonly used in screening chemical compound
libraries.
Conclusion: Nano-porous silicon, when combined with white light interferometry, is a powerful
technique for the measurement of protein-protein interactions. In addition to studying the binary
interactions of biomolecules in clean buffer systems, the newly developed surfaces are also suited
for studying interactions in complex samples, such as plasma.
Protein-protein and protein-DNA interactions are at the
center of cellular regulation. Obtaining a large-scale quan-
titative assessment of protein binding would greatly assist
in system biology modeling, diagnostics, and drug screen-
ing [1]. The sensitive and versatile detection of macromo-
lecular interactions without the aid of fluorescent or
luminescent labels is considered one key goal of proteom-
ics [2]. The cost and potential interference of fluorescent
protein tags or coupled fluorophores with the kinetic
parameters of protein-protein and protein-DNA interac-
tions have led to serious efforts to develop and optimize
label-free detection of proteins. Several technologies have
been developed for that purpose [3-6]. For example, sur-
face plasmon resonance (SPR) performed on gold surfaces
has been the mainstay of detecting interactions between
protein pairs or protein ligand binding [7]. Recently,
other technologies have been employed to measure by
optical interferometry protein-protein interaction of pro-
teins immobilized to the surface of optical fibers or planar
waveguide surfaces [8-11]. The choice of substrates other
than gold has the advantage, other than cost, that these
surfaces can accommodate a wider variety of coupling
chemistries, making them more versatile in terms of
attaching a greater range of molecules.
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This study reports on the use of a defined nano-porous sil-
icon substrate coupled to reflected white-light interferom-
etry to measure refractive index changes on the porous
surface (Figure 1a). When protein is covalently coupled to
the porous surface, or when protein binding to a receptor
surface occurs, the change of refractive index conferred by
the immobilized protein leads to a spectral shift, resulting
in a wavelength shift of the spectrum. This wavelength
shift, called interferogram (Figure 1b), is a measure of pro-
tein mass bound to the surface [12]. Using an industrial
prototype of this technology, built and supplied by Sili-
con Kinetics, Inc. http://www.siliconkinetics.com, we
have been adopting the technology to allow the measure-
ment of protein-protein interactions with surface immo-
bilized receptor molecules. Specifically, incident white
light is projected onto the porous silicon surface.
Reflected light from the porous silicon/fluid interface and
reflected light from the bulk silicon/porous silicon inter-
face are focused onto a diffraction grating from where
emitted light is measured by a photo detector. Shifts in
spectral properties as a result of protein binding are com-
puted and translated into an optical path difference
(OPD) shift, which is proportional to the mass of surface
bound protein. The binding of a ligand to the receptor
molecule generated an OPD shift, demonstrating that the
ligand indeed bound the receptor (Figure 2).
In brief, to generate amine-reactive porous silicon chips,
an activation step with 1-ethyl-3-(3-dimethylaminopro-
pyl) carbodiimide (EDC) and N-hydroxysulfosuccinim-
ide (S-NHS) is required immediately before immobilizing
protein (Figure 3). This approach has the advantage that
the activated surface can react with amines donated by the
unmodified protein to be immobilized, albeit the reac-
tion occurs at lower efficiency when compared to other
surface immobilization chemistries but serves as a stand-
ard method that can accommodate a large number of pro-
tein interaction pairs and groups. Proteins will then be
presented to the activated surface, and will react with
exposed amines with the NHS-moiety donated by the sur-
face [13].
Benzaldehyde activated surfaces have the advantage that
they are stable and can be manufactured in advance of the
reaction with appropriately functionalized proteins (Fig-
ure 3). The immobilization chemistry is based on the effi-
cient reaction between benzaldehyde and an aromatic
hydrazine, which occurs at neutral pH and forms a stable
hydrazone bond [14]. While proteins to be bound to a
benzaldehyde surface need to be functionalized with
hydrazone prior to their immobilization, thus making
this method strictly speaking not label free, this step has
the advantage that large batches of hydrazone functional-
ized protein can be prepared, resulting in greater repro-
ducibility of immobilization as opposed to EDC/S-NHS
ester based immobilization. Furthermore, separating the
functionalization step from the immobilization step has
the advantage that proteins labeled with a hydrazine func-
tional group can be affinity or activity-purified, thus
reducing the pool of molecules inactivated by the labeling
reaction. Due to the more robust chemistry, the surface
can be utilized at higher efficiency, resulting in higher
A) Artist's rendering of nano-porous biosensor principle Figure 1
A) Artist's rendering of nano-porous biosensor principle. B) Schematic representation of interferogram of a typical nano-
porous silicon biosensor experiment. (Source: Silicon Kinetics).Proteome Science 2008, 6:31 http://www.proteomesci.com/content/6/1/31
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labeling densities, hence increasing detection sensitivity.
It is thus possible to label large batches of protein with a
reagent that functionalizes the protein with an aromatic
hydrazone, and to then aliquot and freeze these function-
alized reagents. The reaction of a hydrazine formed from
an aromatic hydrazone in aqueous solution will react
with an aldehyde-functionalized surface after formation
of a Schiff-base to form a stable, covalent hydrazone
bond. Therefore, this reaction has many advantages; it
occurs at neutral pH (and thus compatible with pH-labile
proteins) and leads to higher surface packing densities
that other receptor immobilization methods yielding bet-
ter sensitivity for detection. Given the much lower vari-
ance in immobilization efficiency between different
experiments, it is therefore suited for applications where
large datasets need to be compared across different chips,
or where a higher packing density is needed.
To test different surface immobilization chemistries, their
efficiency of immobilization, stability, ability to interact
with other proteins subsequent to immobilization, and
non-specific binding properties, we resorted to the well-
Overview of optical path and physic of signal acquisition (Source: Silicon Kinetics) Figure 2
Overview of optical path and physic of signal acquisition (Source: Silicon Kinetics).Proteome Science 2008, 6:31 http://www.proteomesci.com/content/6/1/31
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characterized interaction between streptavidin and bioti-
nylated bovine serum albumin (BSA). Specifically, we
immobilized streptavidin to carboxyl surfaces, or to ben-
zaldehyde functionalized surfaces as outlined in the Mate-
rials and Methods section. Immobilized streptavidin was
then exposed to BSA, biotinylated BSA, or 10% lipid-
depleted rat plasma while recording OPD shift in real
time. Succinimidyl 6-hydrazinonicotinate acetone hydra-
zone (HyNic)-labeled streptavidin efficiently and perma-
nently reacts with the aldehyde of the porous silicon
surface, as demonstrated by the stable baseline after wash-
ing. A typical experiment results in an OPD shift of 32
units at an estimated surface coverage of 40% (Figure 4).
This streptavidin-coated surface can efficiently recruit
biotinylated BSA from solution, until equilibrium is
reached. The displacement is typically 13 units. Applica-
tion of 10% (v/v) rat plasma does not yield any significant
modulation in binding activity, suggesting that the ben-
zaldehyde surface is well suited for applications where
elimination of non-specific binding is paramount. To test
the extent of non-specific binding at higher plasma con-
centration, we incubated a benzaldehyde surface with
increasing amounts of rat plasma (Figure 5). With a low
plasma concentration of 10% (v/v), we do not observe
surface binding as measured by OPD shift, however,
increased concentrations of 20 to 40% (v/v) do indeed
show a low degree of temporary non specific binding dur-
ing sample application. Surfaces exposed to such high
plasma concentrations still remain competent for recruit-
ing specific proteins, suggesting that even at plasma con-
centrations much higher than the commonly used 10%
diluted plasma, are still compatible with the nano-porous
silicon surfaces used in this study.
Based on our observations above, the OPD shift repre-
sents a measure of protein interaction with the surface and
is a valid approach that accurately describes the kinetics of
the reaction. To test the compatibility of the platform with
Nano-porous silicon immobilization chemistries Figure 3
Nano-porous silicon immobilization chemistries. Top row: Carboxyl chemistry. Carboxyl functionalized nano-porous silicon 
chips (1) are activated and functionalized with EDC/sulfo-NHS. The sulfo-NHS ester functionalized surface (2) will react with 
amines contributed by the protein to be immobilized (3), leading to the formation of a stable amine bond between protein and 
surface (4). Bottom row: The protein to be immobilized is reacted with the bifunctional HyNic reagent (1), which will react 
with amines contributed from the protein to form hydrazine-functionalized protein. The hydrazine-functionalized protein is 
reacted with benzaldehyde functionalized nano-porous silicon surface (2), which will lead to a stable attachment of the protein 
to the surface through a hydrazone bond (3).Proteome Science 2008, 6:31 http://www.proteomesci.com/content/6/1/31
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solvents typically used in screening of small molecule
libraries, we tested the effect of 5% dimethylsulfoxide
(DMSO) and 2% dimethylformamide (DMF) on the
OPD-shift reading (data not shown). DMSO and DMF
had no effect on the binding of our reference proteins sug-
gesting that accurate measurements of interaction can be
accomplished in the presence of compounds solubilized
in these common organic solvents [15].
Many research and clinical studies require the analysis of
individual proteins that are part of a complex mixture of
proteins, such as plasma, cerebrospinal fluid, urine, and
saliva. Key in these applications is to minimize non-spe-
cific interactions of random proteins with the surface,
which could interfere with the specificity of binding and
thus authenticity of results.
Typically for an experiment, we first ensured that the sam-
ple and reference flow cells are identical. Figure 6a shows
that indeed sample and reference cells are identical in
terms of being able to immobilize equivalent amounts of
HyNic functionalized streptavidin (HyNicSA) to a benzal-
dehyde surface. Using the same flow cell with a new chip,
we further demonstrate that there is no appreciable differ-
ence in either rate or absolute quantity of HyNicSA bind-
ing to the surface, suggesting that the aromatic hydrazone
benzaldehyde reaction is not affected by the presence of
other proteins (Figure 7a). These surfaces are equally com-
petent in being able to bind biotinylated substrates (Fig-
ure 7b). We then exposed a streptavidin surface to either
biotinylated BSA (bBSA) dissolved in 10% (v/v) delipi-
dated rat plasma (sample), or dissolved in PBS, pH 7.2
(reference). As shown in figure 7b, there is no significant
difference in either rate or quantity of biotinylated BSA
binding when the protein is recruited from buffer, or from
a complex protein mixture such at rat plasma, correspond-
ing to a 50 fold excess protein mass. Similarly, 10% (v/v)
fetal calf serum supplemented modified Eagles medium,
does not impede the recruitment of bBSA when compared
to bBSA binding alone (Figure 7c). This holds until much
higher concentration of sera is utilized (typically 25% (v/
v) for the proteins tested).
Typical full immobilization and binding run with non-specific binding test using a benzaldehyde biochip and hydrazone cross- linking chemistry Figure 4
Typical full immobilization and binding run with non-specific binding test using a benzaldehyde biochip and hydrazone cross-
linking chemistry. The signal shown is the result of subtracting the sample channel from the reference from the differential flow 
cells used with Ski Pro. 50 μL sample and reference volumes each were exposed to the sensor surface over 500 seconds. We 
applied 0.5 mg/mL HyNic-labeled streptavidin in the sample channel and conjugation buffer in the reference channel for 500 
seconds, followed by 0.1 mg/mL biotinylated BSA. 10% delipidated rat plasma was run as a non-specific binding control.Proteome Science 2008, 6:31 http://www.proteomesci.com/content/6/1/31
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We primarily focused on a strong protein-biotin interac-
tion to evaluate the stability of the surface. However, most
kinetic experiments on this and other platforms include
weaker protein-protein interactions. We therefore
extended our analysis to other common protein-protein
interaction pairs, such as antibody antigen interactions.
We established that just like streptavidin, HyNic-function-
alized human immunoglobulin can be immobilized to a
benzaldehyde surface and that anti human IgG binds to
this surface (Figure 8).
To directly compare the limit of detection of the nanopo-
rous silicon interferometry based platform to a traditional
SPR platform, we used identical batches of proteins to
immobilize and ligands to be recruited to the surface. A
typical nanoporous silicon interferometry experiment
shows that human IgG/anti-human IgG can be detected at
100 ng/mL (Figure 9a), while on a SPR instrument the
detection is slightly less sensitive at 1 μg/mL (Figure 9b).
Dose response at the binding maximum confirms these
original data (Figure 9c).
To test the influence of complex samples on the kinetics
of interaction between human IgG and anti-human IgG,
we calculated KD and on-rates for the interactions in the
presence and absence of 10% delipidated rat plasma,
using a fixed surface density of 18 OPD and 4000 RU,
respectively, and varying anti-human IgG at 0, 0.1, 1, 10
and 100 μg/mL (Figure 10). While the on-rates are com-
parable between the two platforms, the presence of
plasma seems to alter the on rate on the SPR platform but
not on the nanoporous silicon interferometry platform.
The KD values on the nanoporous silicon interferometry
platform are consistently lower and not as much subject
to interference of complex mixtures when compared to a
SPR detection method, which may be caused by differ-
ences and accessibility of surface bound receptors.
Discussion
We demonstrate the utility and flexibility of a detection
method that combines a porous silicon substrate with
white-light optical interferometry to measure protein-pro-
tein interactions taking place at the surface. Using either a
well understood EDC/S-NHS ester immobilization chem-
istry to attach a receptor to the surface, or a benzaldehyde
surface immobilization chemistry that involves function-
alizing the receptor in solution though incorporation of
hydrazine label, we exemplify how such a biosensor can
be used to measure protein-protein interactions. The latter
approach enables to efficiently and reproducibly generate
Non-specific binding properties of benzaldehyde-functionalized nanoporous silicon surface Figure 5
Non-specific binding properties of benzaldehyde-functionalized nanoporous silicon surface. Increasing concentrations of rat 
plasma, diluted in PBS buffer with 0.05 g/L citrate, were applied to a chip, using PBS as reference. Application of 10% (v/v) 
diluted plasma does not lead to an appreciatable amount of binding, while 20% (v/v) and 40% (v/v) rat plasma lead to a tempo-
rary signal during sample application. After exposure to complex plasma mixtures, the chip surface remains competent for spe-
cific binding with HyNic-activated streptavidin (SA). The negative signal in 0% (v/v) and 10% (v/v) rat plasma is likely due to 
buffer effects. 50 μL sample and reference volumes each were exposed to the sensor surface over 500 seconds.Proteome Science 2008, 6:31 http://www.proteomesci.com/content/6/1/31
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receptor surfaces for kinetic and high-throughput applica-
tions by minimizing sample-to sample or chip-to-chip
variability. This approach also allows to establish protein
functionalization conditions coupled to activity based
enrichment methods (e.g. affinity purification of antibod-
ies) to ensure that the immobilized receptor retains bio-
logical function, prior to immobilization on the porous
silicon surface.
A comparison of specific protein recruitment from buffer
or from a complex mixture of proteins demonstrates that
the porous silicon chips are able to specifically recruit pro-
teins to either a chemical or to a protein affinity surface. It
is now possible to either use hydrazone-functionalized
proteins, or biotinylated proteins, or similar affinity rea-
gents to recruit proteins and protein complexes from rele-
vant biological protein mixtures.
The combination of sensitivity with very low non-specific
binding enable this platform to be used directly on com-
plex samples. For example, in the field of protein diagnos-
tics, testing for autoimmune diseases could be readily
adapted to this platform by providing antigens and deter-
mining the presence of antibodies in the sera of patients.
Severity of the disease could be a function of the breadth
of reactivity against a greater number of self-antigen,
higher affinity or amount of circulating antibodies. Simi-
larly, allergen testing could be performed by immobiliz-
ing allergens on a biochip and screening for the presence
of antibodies in patients that bind to the allergen. Con-
ceptually, the instrument platform could test for small
molecules with therapeutic potential in an indirect fash-
ion. The approach would be to allow interaction of two
proteins of interest and introduce the small molecule
compound(s) and determine if the compound modulates
the original protein-protein interaction.
Methods
Reagents and Supplies
Unless otherwise mentioned, all chemicals and reagents
were obtained from Sigma-Aldrich (St. Louis, MO). Suc-
cinimidyl 6-hydrazinonicotinate acetone hydrazone (S-
HyNic; S1002), 10 × modification buffer, 10 × conjuga-
tion buffer, and DMF were purchased from Silicon Kinet-
ics (San Diego, CA). Carboxy-functionalized and
benzaldehyde functionalized nanoporous silicon bio-
Sample (green) and reference (blue) cells behave identically during HyNic-functionalized deposition of 0.5 mg/mL HyNic func- tionalized streptavidin, indicating that sample flow and deposition chemistries occur at similar rate Figure 6
Sample (green) and reference (blue) cells behave identically during HyNic-functionalized deposition of 0.5 mg/mL HyNic func-
tionalized streptavidin, indicating that sample flow and deposition chemistries occur at similar rate. 50 μL sample and reference 
volumes each were exposed to the sensor surface over 500 seconds.Proteome Science 2008, 6:31 http://www.proteomesci.com/content/6/1/31
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A) Immobilization of 0.5 mg/mL HyNic-functionalized streptavidin from PBS buffer (blue) and from 10% (v/v) rat plasma diluted  in PBS (green) Figure 7
A) Immobilization of 0.5 mg/mL HyNic-functionalized streptavidin from PBS buffer (blue) and from 10% (v/v) rat plasma diluted 
in PBS (green). B) Immobilization of 0.1 mg/ml biotinylated BSA from PBS buffer (blue) and from 10% (v/v) rat plasma diluted in 
PBS (green) onto a 40% saturated streptavidin surface. C) Immobilization of 0.1 mg/ml biotinylated BSA from PBS buffer (blue) 
and from DIMEM medium supplemented with 5% (v/v) fetal bovine calf serum (green) onto a 40% saturated streptavidin sur-
face. 50 μL sample and reference volumes each were exposed to the sensor surface over 500 seconds.Proteome Science 2008, 6:31 http://www.proteomesci.com/content/6/1/31
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chips were from Silicon Kinetics (San Diego, CA).
Immuno-pure streptavidin (21125), consumables, and
plastic ware were supplied by Thermo Fisher (Waltham,
MA). ZEBA columns were from Pierce, now Thermo Fisher
(Waltham, MA).
Surface Immobilization
To produce hydrazine-functionalized streptavidin, 5 mg
of lyophilized streptavidin was dissolved in 0.5 mL of
water. The dissolved streptavidin was equilibrated into
PBS buffer, pH 7.2, using ZEBA columns. 1 mg S-HyNic
was dissolved in 0.03 mL anhydrous DMF. After complete
solubilization of the S-HyNic reagent, 15 μL of the reagent
was added to the dissolved protein, followed by immedi-
ate rapid vortexing. After incubation of the labeling reac-
tion at room temperature for 4 hours, unincorporated S-
HyNic reagent was removed and buffer exchange into
PBS, pH 6.0, performed using a ZEBA column. If needed,
the protein concentration of the protein solution was
adjusted, and aliquots of the now hydrazone-functional-
ized protein were frozen and stored at -20C, or directly
processed. 50 μL of a 1 mg/mL HyNic-streptavidin solu-
tion in PBS, pH 6.0, was applied to a benzaldehyde nano-
porous silicon chip at a flow rate of 10 μL/min, followed
by an exchange into PBS, pH 7.2. 50 μL of a 200 μg/mL
biotinylated BSA solution was applied at a flow rate of 10
μL/min, followed by a wash step and application of 50 μL
of a 10% v/v rat plasma solution diluted into PBS buffer,
pH 7.2 to test for non-specific binding.
Alternatively, 50 μL of a 1 mg/mL HyNic-streptavidin
solution in PBS, pH 6.0, was applied as a comparison (ref-
erence). In a separate experiment 50 μL of a 200 μg/mL
biotinylated BSA solution in 10% delipidated rat plasma
(sample), or in PBS buffer, pH 7.2 (reference), was
applied at a flow rate of 10 μL/min, followed by a buffer
step to test for dissociation.
Typical full immobilization and binding run using a benzaldehyde biochip and hydrazone cross-linking chemistry Figure 8
Typical full immobilization and binding run using a benzaldehyde biochip and hydrazone cross-linking chemistry. The signal 
shown is the result of subtracting the sample channel from the reference from the differential flow cells used with Ski Pro. 50 
μL sample and reference volumes each were exposed to the sensor surface over 500 seconds. We applied 0.2 mg/ml HyNic-
labeled human immunoglobulin in the sample channel and conjugation buffer in the reference channel for 500 seconds, followed 
by 0.1 mg/mL anti human IgG.Proteome Science 2008, 6:31 http://www.proteomesci.com/content/6/1/31
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Carboxyl-chip immobilization
To immobilize human immunoglobulin G (IgG) onto
nanoporous silicon (SKi Pro) or a CM-5 gold surface
(Biacore), we followed the manufacturers guidelines for
immobilization. In brief, surfaces were activated with
EDC/S-NHS, and 100 μg/ml human IgG was exposed
either 5 (SKi Pro) or 3 minutes (Biacore 3000) to the acti-
vated surface. The surface was then blocked with 1 M eth-
anoleamine solution for 20 minutes and equilibrated into
PBS running buffer. A reference surface was prepared by
activating and subsequently blocking the surface under
identical conditions.
Data Acquisition and Analysis
All data obtained in this study were acquired on a Silicon
Kinetics Ski Pro system, and data were analyzed using a
beta version of the SKi Report software. Raw data were
smoothed through averaging every ten data points and
zeroed using the appropriate function keys. Biacore data
were obtained on a Biacore 3000 system and analyzed
using instrument-specific software.
Comparison of SKiPro and Biacore 3000, using EDC/S-NHS chemistry Figure 9
Comparison of SKiPro and Biacore 3000, using EDC/S-NHS chemistry. An 18 OPD nanoporous silicon carboxyl chip (SKi Pro) 
and a 4000 RU CM-5 chip (Biacore) were prepared by immobilizing human IgG from a 0.1 mg/mL solution, using identical EDV/
S-NHS immobilization conditions in concordance with each manufacturer's protocols. Anti-human IgG was applied at 0, 100 
ng/mL, 1 μg/mL, 10 μg/mL, and 100 μg/mL in ascending order. Each chip was regenerated by incubation with 25 mM glycine 
buffer, pH 2.0 for 20 minutes between exposures. Kinetic traces were displayed with SKi Pro A) or Biacore 3000's proprietary 
software B). Concentration response curves were drawn in OPD (SKi Pro) and RU (Biacore) agains the concentration in μg/
mL. Limit of detection for this particular protein pair is 100 ng/mL on the SKi Pro, and 1 μg/mL on the Biacore 3000 platform 
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Kinetics of human IgG and anti human IgG interaction meas- ured by nanoporous silicon interferometry and surface plas- mon resonance (SPR) Figure 10
Kinetics of human IgG and anti human IgG interaction meas-
ured by nanoporous silicon interferometry and surface plas-
mon resonance (SPR). Kinetics of 0, 0.1, 1, 10 and 100 μg/mL 
anti-human IgG were measured using each platforms propri-
etary software and are tabulated.